NCT00338507View on ClinicalTrials.gov

Phase 2 Study - Erdosteine in Patients With CB/COPD

PHASE2CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

March 31, 2006

Conditions
Chronic BronchitisChronic Obstructive Pulmonary Disease
Interventions
DRUG

Erdosteine

Trial Locations (1)

19406

Omnicare Clinical Research, King of Prussia

Sponsors
All Listed Sponsors
lead

Adams Respiratory Therapeutics

INDUSTRY

NCT00338507 - Phase 2 Study - Erdosteine in Patients With CB/COPD | Biotech Hunter | Biotech Hunter